BIOGEN IDEC $235.24

up +2.62


24/5/2013 04:24 PM  |  NASDAQ : BIIB  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing
Last Trade: 235.24
Trade Time: May 24 4:42 PM Eastern Daylight Time
Change: 2.62 (1.13 %)
Prev Close: 232.62
Open: 230.87
Bid: 235.24
Ask: 0.00
Quotes displayed are delayed by 15 minutes. Market data is provided by Telvent DTN

ETF Alternatives



People viewing BIIB also viewed: , , , ,

Competitors

Ticker Name Volume % Change
NPCUF ALLON THERAPEUTICS INC 10.0K +1.78%
CNSO CNS RESPONSE 34.1K +1.26%
ISLT ISLET SCIENCES 78.6K +0.75%
ADLS ADVANCED LIFE SCIENCES 35.1K +0.67%
SCLR SCOLR PHARMA 427.3K +0.67%

Insider Transactions

Date Name Title Volume Trade Price Holding Change
5/3/2013 Pawlicki Raymond SVP, Chief Information Officer -866 $218.85 -9.04%
5/3/2013 Cox John EVP Pharmaceutical Oper & Tech -866 $218.85 -4.58%
5/1/2013 COVINO GREGORY F VP, Chief Accounting Officer -114 $214.33 -23.31%
5/1/2013 SCANGOS GEORGE A Chief Executive Officer -1,598 $215.39 -3.07%
4/30/2013 Clancy Paul J Executive VP and CFO -900 $226.01 -11.27%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (BIIB), click here.

BIIB Stock Analysis

  1. Amgen Chased By The Bubble

    Amgen really needs the pipeline to come through to support this valuation.
Free Reports
  1. Forbes Quant Model: 3 Top Stocks

    Using Forbes’ exclusive Quant Model, we’ve chosen three stocks that we think could double in price in the next 12 months.
  2. Get 4 quotes FREE - Refinance and Save

    Instant matching service with top lenders.
  3. Forbes Wolfe Nanotech Report Nanotech 101

    Get this Rare, First-Person Account of the Nanotechnology Industry, Absolutely Free!
Marketplace
Trading Center